Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Deforolimus (Ridaforolimus)
Cat No.
CEI-0129
Description
Deforolimus (Ridaforolimus, AP23573, MK-8669) can inhibit mTOR with IC50 of 0.2 nM.
Alias
AP23573, MK-8669
CAS No.
572924-54-0
Molecular Weight
990.21
Purity
>99%
Storage
2 years at -20centigrade Powder
Synonyms
AP23573, MK-8669
Targets
mTOR
Molecular Formula
C53H84NO14P
Solubility
DMSO 198 mg/mL Water
In vitro
Deforolimus can inhibit phosphorylation of S6 and 4E-BP1 with IC50 of 0.2 nM and 5.6 nM in HT-1080 cells in a dose-dependent manner. Deforolimus can also induce cell cycle arrest in G1 phase and inhibit glucose uptakeing, resulting in decreaseing the size of cells.
In vivo
Administration of Deforolimus exerts significant antitumor effects in mice bearing PC-3 (prostate), HCT-116 (colon), MCF7 (breast), PANC-1 (pancreas) or A549 (lung) xenografts in a dose-dependent manner.
Download
Download Datasheet